Search Orphan Drug Designations and Approvals
-
Generic Name: | recombinant human histone H1.3; recombinant human N-bis-met-histone H1.3 |
---|---|
Date Designated: | 10/20/2008 |
Orphan Designation: | Treatment of acute myeloid leukemia |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Xenetic Biosciences Plc London Bioscience Innovation Centre 2 Royal College Street London United Kingdom The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-